BioMed Realty Will Secure $915 Million Mortgage Loan
The Cambridge life science property deal is scheduled to close on October 15, 2026.
Updated on Sept. 30, 2026 in Biotech
Live Poll
Is now a good time to invest in large-scale life science commercial real estate projects?
BioMed Realty is set to finalize a $915 million interest-only, two-year floating-rate mortgage loan for its life science property in Cambridge on October 15, 2026. The transaction will successfully retire $490 million in existing debt on the facility.
Why it matters
The financing arrangement provides capital to cover significant landlord obligations and closing costs for the large-scale development. By securing this debt, the company stabilizes the financial footing of a major site occupied by Takeda Pharmaceuticals.
The 598,502-square-foot life science facility is designed for specialized biotech research. Takeda Pharmaceuticals has committed an additional $350 million to finalize the lab space interior.
The players
BioMed Realty
This company is a major owner and operator of life science real estate properties.
Takeda Pharmaceuticals
This global research-based biopharmaceutical company is the anchor tenant for the property.
KeyBank
This financial institution acts as the loan servicer and special servicer for the transaction.
The details
The loan involves a consortium of lenders including Wells Fargo Bank, Citi Real Estate Funding Inc., Goldman Sachs Bank USA, JPMorgan Chase Bank, and the Royal Bank of Canada. The facility features three one-year extension options and covers $129.5 million in outstanding landlord obligations.
Timeline
Construction broke ground on the property in October 2022.
The building reached its topping-off stage in January 2025.
The first lease phase for the property commenced in June 2026.
The mortgage deal is scheduled to close on October 15, 2026.
Takeda Pharmaceuticals move-in is slated for March 2027.
The Tech Race
This project represents the continued expansion of high-density biotech infrastructure near academic anchors like the MIT campus. It follows a trend of consolidating global pharmaceutical operations into dedicated, modern laboratory ecosystems.
The transition of this facility into active lab space will drive regional economic activity and employment in the biotech sector. Local residents may see increased professional traffic in the Kendall Street area as the move-in process begins.
The takeaway
Large-scale biotech real estate projects require significant, multi-phase financing to transition from ground-breaking to fully operational laboratory environments. Investors should monitor these long-term lease commitments as indicators of regional sector health.
Further reading
For more information on the local industry, visit the Biotech section.
Source note: This article includes information reported by Commercial Property Executive.
Live Poll
Is now a good time to invest in large-scale life science commercial real estate projects?
